Table 1.
Tumor Cell Line |
EEV Ratio (ΔSCR:B5R) | IMV Ratio (ΔSCR:B5R) | |
---|---|---|---|
Type | Name | ||
Ovarian | A2780 | 6.333** | 1.523 |
CaOV3 | 7.159*** | 1.657* | |
RMG-1 | 1.825** | 0.75 | |
SKOV3 | 1.835* | 1.161 | |
Pancreatic | AsPC1 | 0.969 | 0.837 |
BxPC3 | 0.091*** | 0.551 | |
Panc1 | 0.418** | 0.249** | |
SW1990 | 0.952 | 0.636 | |
Colon | Caco2 | 0.992 | 0.968 |
HT29 | 0.229** | 0.279** | |
LoVo | 2.719* | 0.654 | |
SW480 | 0.254* | 0.961 | |
Lung | A549 | 4.634*** | 0.425** |
Breast | MCF-7 | 0.913 | 1.217 |
SK-BR-3 | 1.223 | 0.664 | |
Hepatocellular | HepG2 | 3.164** | 1.242 |
Neuroblastoma | SK-N-AS | 0.766 | 0.621 |
SK-N-BE | 0.335 | 0.676 | |
Epidermoid | A431 | 1.132 | 1.198 |
Hep2 | 0.436* | 1.267 |
Various tumor cell lines were infected with B5R or ΔSCR at an MOI of 0.1. EEVs and IMVs were recovered from the cultures 48 h later, and they were titrated in RK13 cells as described in Figure 1C. The table shows the progeny virus productive ratio of ΔSCR to B5R. Titers are listed in Figure S2. *p < 0.05, **p < 0.01, ***p < 0.001 (unpaired t test).